AddictionVIA-MGNCT05163171
Prevalence of the Victimization and the Perpetration of Intimate Partner Violence Among the Patients From Puy-de-Dôme and Paris Consulting or Being Hospitalized for Addiction Problems and Their Expectations From General Practitioners (VIA-MG)
An observational study of Addiction and Violence, Domestic, run by University Hospital, Clermont-Ferrand at 1 site in France.
Trial summary
Intimate partner violence and addictions are two frequent problematics with many consequences on health. A link between intimate partner violence and addictions has been found in many studies. Being a drug user increases the risk to be a perpetrator and also a victim of intimate partner violence. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Addiction, Violence, Domestic
- What is being tested?
- questionnaire
- How many people
- 122 participants
- Where
- 1 siteFrance
- Study dates
- 10 Jan 2022to 20 Jul 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients consulting or being hospitalized for addiction problems
Who may be able to join
- Patient over 18, being or having been in a relationship, consulting or being hospitalized for an addiction problem
- Patient speaking and writing French
- Patient capable of giving his informed consent to take part to the study
- Affiliation to the social security
- Patient who doesn't have a tobacco addiction only
Who cannot join
- refuse to participate
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Prevalence of the Victimization and the Perpetration of Intimate Partner Violence Among the Patients From Puy-de-Dôme and Paris Consulting or Being Hospitalized for Addiction Problems and Their Expectations From General Practitioners
Intimate partner violence and addictions are two frequent problematics with many consequences on health. A link between intimate partner violence and addictions has been found in many studies. Being a drug user increases the risk to be a perpetrator and also a victim of intimate partner violence.
So, it is legitimate to question ourselves about the prevalence of the victims and perpetrators of intimate partner violence among the patients consulting or being hospitalized for an addiction problem. We believe that this prevalence will be high among these patients.
On the other hand, the general practitioners are in first line receiving victims and perpetrators of violence and patients with addiction problems. So it is important to know the profiles of these patients and their expectations from their general practitioners.
Read the detailed description
The different places where the study will take place are:
- 7 outpatient addiction centers: Addictology consultations in CHU Clermont-Ferrand, CH Sainte-Marie, CH Thiers, CH Ambert, ANPAA (Association Nationale de Prévention en Alcoologie et en Addictologie) of Clermont-Ferrand, Thiers and Ambert.
- 3 hospital addiction centers: Addictology hospital services of CHU of Clermont-Ferrand, CH Thiers and Clémentel.
This study will be based on the filling of self-answered questionnaires by the patients consulting or being hospitalized in the different recruited centers. The questionnaire will be proposed to the patient after the consultation with the practitioner. An information about the study and the anonymity will be given to the patient. The filled questionnaire will be put by the patient in a closed envelope and then in a collection box located in the waiting room.
The different boxes of the different centers will be checked regularly and then the questionnaires will be analysed. The analysis of these questionnaires will allow to describe the population consulting or being hospitalized for addiction problems in the Puy-de-Dôme: age, gender, type of the addiction, the presence of intimate partner violence, associated factors of the violence, recourse characteristics to general practitioners and expectations of GP. We will evaluate the prevalence of victimization and perpetration of intimate partner violence among patients consulting or being hospitalized for addiction problems in the Puy-de-Dôme.
We estimate the duration of the study at around 6 months.
- Conditions
- Addiction, Violence, Domestic
- Being tested
- questionnaire
- Keywords
- General practice, Intimate partner violence
- Medical subject headings
- Behavior, Addictive
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
questionnaireOther
questionnaire for conjugal violence prevalence
| Study group | Role | What they receive |
|---|---|---|
| patient consulting or hospitalized in addiction structure | patient consulting or hospitalized in addiction structure Receives: Other: questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of the victimization
Prevalence of the victimization and the perpetration of intimate partner violence in patients consulting or being hospitalized for addiction problems who had filled the questionnaire. This prevalence will be measured by the filling of the questions of the self-answered questionnaire by the patients.
Measured: day 0
Secondary outcomes (5)
Prevalence of each addiction
prevalence will be measured by the filling of the questions of the self-answered questionnaire by the patients.
Measured: Day 0
Socio-demographic characteristics
age in years
Measured: Day 0
Socio-demographic characteristics
male or female
Measured: Day 0
Recourse at general practitioner characteristics
reason and frequency of consultation with their general practitioner
Measured: Day 0
Expectations by the patients of the general practitioners about addictions and intimate partner violence
qualitative answer
Measured: Day 0
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Dec 2021
- Study start10 Jan 2022
- Primary completion20 Jul 2022
- Study completion20 Jul 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for AddictionStudies of the same condition, open and under way.
- More trials run by University Hospital, Clermont-FerrandThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 122 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Sponsor type
- University, hospital or other
- Collaborators
- General medicine department of Clermont-Ferrand's university
- Responsible party
- Sponsor
- Investigators
- Mathilde VICARD-OLAGNE, Principal investigator, University Hospital, Clermont-Ferrand
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05163171
- Sponsor's protocol ID
- RNI 2021 VICARD-OLAGNE
- Other IDs
- 2021-A01356-35
- Acronym
- VIA-MG
- Status last verified
- Jul 2022
- First submitted
- 6 Dec 2021
- Last updated
- 31 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Kadri A, Clergue-Duval V, Lambert C, Atger L, Chouchana M, de Chazeron I, Questel F, Laporte C, Brousse G, Vorspan F, Vicard-Olagne M. Is Cocaine Use Associated with Intimate Partner Violence in Patients from Addiction Centers? Subst Use Misuse. 2025;60(11):1577-1582. doi: 10.1080/10826084.2025.2506144. Epub 2025 Jun 20.
PubMed 40540727
Study at a glance
From the registry record, last updated by the sponsor on 31 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence of the Victimization and the Perpetration of Intimate Partner Violence Among the Patients From Puy-de-Dôme and Paris Consulting or Being Hospitalized for Addiction Problems and Their Expectations From General Practitioners
- ClinicalTrials.gov ID
- NCT05163171
- Acronym / sponsor ID
- VIA-MG / RNI 2021 VICARD-OLAGNE
- Conditions
- Addiction, Violence, Domestic
- Keywords
- General practice, Intimate partner violence
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 122 participants (actual)
- Lead sponsor
- University Hospital, Clermont-FerrandUniversity, hospital or other
- Collaborators
- General medicine department of Clermont-Ferrand's university
- Study start
- 10 Jan 2022 (actual)
- Primary completion
- 20 Jul 2022 (actual)
- Study completion
- 20 Jul 2022 (actual)
- First posted
- 20 Dec 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Intimate partner violence and addictions are two frequent problematics with many consequences on health. A link between intimate partner violence and addictions has been found in many studies. Being a drug user increases the risk to be a perpetrator and also a victim of intimate partner violence.
So, it is legitimate to question ourselves about the prevalence of the victims and perpetrators of intimate partner violence among the patients consulting or being hospitalized for an addiction problem. We believe that this prevalence will be high among these patients.
On the other hand, the general practitioners are in first line receiving victims and perpetrators of violence and patients with addiction problems. So it is important to know the profiles of these patients and their expectations from their general practitioners.
Detailed description
The different places where the study will take place are:
- 7 outpatient addiction centers: Addictology consultations in CHU Clermont-Ferrand, CH Sainte-Marie, CH Thiers, CH Ambert, ANPAA (Association Nationale de Prévention en Alcoologie et en Addictologie) of Clermont-Ferrand, Thiers and Ambert.
- 3 hospital addiction centers: Addictology hospital services of CHU of Clermont-Ferrand, CH Thiers and Clémentel.
This study will be based on the filling of self-answered questionnaires by the patients consulting or being hospitalized in the different recruited centers. The questionnaire will be proposed to the patient after the consultation with the practitioner. An information about the study and the anonymity will be given to the patient. The filled questionnaire will be put by the patient in a closed envelope and then in a collection box located in the waiting room.
The different boxes of the different centers will be checked regularly and then the questionnaires will be analysed. The analysis of these questionnaires will allow to describe the population consulting or being hospitalized for addiction problems in the Puy-de-Dôme: age, gender, type of the addiction, the presence of intimate partner violence, associated factors of the violence, recourse characteristics to general practitioners and expectations of GP. We will evaluate the prevalence of victimization and perpetration of intimate partner violence among patients consulting or being hospitalized for addiction problems in the Puy-de-Dôme.
We estimate the duration of the study at around 6 months.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| patient consulting or hospitalized in addiction structure | – | Other: questionnairepatient consulting or hospitalized in addiction structure |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients consulting or being hospitalized for addiction problems
Key inclusion criteria (5 listed)
- Patient over 18, being or having been in a relationship, consulting or being hospitalized for an addiction problem
- Patient speaking and writing French
- Patient capable of giving his informed consent to take part to the study
- Affiliation to the social security
- Patient who doesn't have a tobacco addiction only
Key exclusion criteria (1 listed)
- refuse to participate
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| questionnairequestionnaire for conjugal violence prevalence | Other | patient consulting or hospitalized in addiction structure |
Primary outcome
Prevalence of the victimization
Time frame: day 0
Prevalence of the victimization and the perpetration of intimate partner violence in patients consulting or being hospitalized for addiction problems who had filled the questionnaire. This prevalence will be measured by the filling of the questions of the self-answered questionnaire by the patients.
5 secondary outcomes
Prevalence of each addiction
Time frame: Day 0
Socio-demographic characteristics
Time frame: Day 0
Socio-demographic characteristics
Time frame: Day 0
Recourse at general practitioner characteristics
Time frame: Day 0
Expectations by the patients of the general practitioners about addictions and intimate partner violence
Time frame: Day 0
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Jul 2026.
- Results publication: PubMed 40540727Kadri A, Clergue-Duval V, Lambert C, Atger L, Chouchana M, de Chazeron I, Questel F, Laporte C, Brousse G, Vorspan F, Vicard-Olagne M. Is Cocaine Use Associated with Intimate Partner Violence in Patients from Addiction Centers? Subst Use Misuse. 2025;60(11):1577-1582. doi: 10.1080/10826084.2025.2506144. Epub 2025 Jun 20.
Related trials for Addiction
Not yet recruiting
Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support
People Who Use Opioids/People With Opioid Use Disorder (OUD)
Not yet recruiting
Low-Intensity Focused Ultrasound for Gambling Disorder
Gambling Disorder, Gambling Addiction
Not yet recruiting
Compulsive Eating and Brain's Reward System in Different Pathologies
PARKINSON DISEASE (Disorder), Bipolar 1 Disorder
Recruiting
The Trans-Led Care Study
Substance Abuse, Substance Addiction
Enrolling by invitationObservational study
Addictions Neuroclinical Assessment (ANA)
Normal Physiology, Alcohol Use Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mathilde VICARD-OLAGNE principal investigator
University Hospital, Clermont-Ferrand
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Addiction and Violence, Domestic, run by University Hospital, Clermont-Ferrand at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of the victimization (time frame: day 0). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05163171, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2026.